InvestorsHub Logo
Followers 2
Posts 2022
Boards Moderated 0
Alias Born 05/11/2017

Re: raja48185 post# 76423

Monday, 07/30/2018 8:21:57 AM

Monday, July 30, 2018 8:21:57 AM

Post# of 108192
If they are going to shut down Aim2Cerv and any other AXAL based trials, they might be able to run this small trial on their own. They need approximately 10 patients for Ph1/2, which costs about ~100K/patient. Doable, but really walking on a tight rope.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News